Clinical Trials in San Antonio

Showing 6541-6560 of 14,633 trials

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

NCT05508568

The objective of this prospective, multi-centre study is to evaluate the performance of ADXBLADDER, a urine MCM5 ELISA test, as an aid in the detection of bladder cancer recurrence. Patients undergoing cystoscopic surveillance in non-muscle invasive bladder cancer (NMIBC) follow-up will be recruited and asked to provide a urine sample to be tested with ADXBLADDER. To assess the diagnostic accuracy of the test, the MCM5 results will be compared with the gold standard cystoscopy and pathology of resected tissue.

Bladder Cancer

Arquer Diagnostics Ltd650 participantsStarted Jul 2021

Denver, Colorado, United States • Daytona Beach, Florida, United States • Jeffersonville, Indiana, United States +10 more locations

TERMINATEDPhase 3< 1 mile

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

NCT03802630

The purpose of this study was to evaluate the efficacy and safety of brolucizumab in treatment of patients with macular edema (ME) secondary to branch retinal vein occlusion (BRVO).

Branch Retinal Vein Occlusion

Novartis Pharmaceuticals450 participantsStarted Jul 2019

Phoenix, Arizona, United States • Mountain View, California, United States • Santa Barbara, California, United States +99 more locations

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

Find Trials by Condition in San Antonio

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Shape Up! Kids Study

Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

Rectal Microbicide Acceptability, Tolerability and Adherence

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

Neuro RX Gamma - Pivotal Phase

Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment